Co-diagnostics, inc. wins dismissal of class action lawsuit

Salt lake city , march 6, 2025 /prnewswire/ -- co-diagnostics, inc. (nasdaq: codx) (the "company" or "co-dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that on march 4, 2025, the securities & governance litigation team at bakerhostetler, the legal firm retained to represent the company, won complete dismissal on summary judgment of a section 10(b) securities class action that had been pending against the company in the united states district court for the district of utah. see gelt trading, ltd.
CODX Ratings Summary
CODX Quant Ranking